LeonaBio (LONA) Return on Capital Employed (2020 - 2026)

LeonaBio (LONA) has 7 years of Return on Capital Employed data on file, last reported at 146.19% in Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 3506.0% year-over-year to 146.19% in Q1 2026; TTM through Mar 2026 was 146.19%, a 3506.0% increase from a year earlier, with the FY2025 full-year figure at 365.73%, down 26104.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 146.19%, up from 752.56% in the prior quarter.
• Over the last five years, Return on Capital Employed for LONA reached as high as 24.48% in Q1 2022 and fell as low as 752.56% in Q4 2025.
• Historically, Return on Capital Employed has averaged 137.67% across 5 years, with a median of 101.76% in 2024.
• Across the five-year window, Return on Capital Employed sank 58263 bps in 2025 and surged 3506 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 42.5% in 2022, then tumbled by 106 bps to 87.35% in 2023, then tumbled by 95 bps to 169.93% in 2024, then slumped by 343 bps to 752.56% in 2025, then surged by 81 bps to 146.19% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 146.19% in Q1 2026, 752.56% in Q4 2025, and 130.88% in Q3 2025.